Secondary Logo

Journal Logo

October 2007 - Volume 30 - Issue 5
pp: 461-567


Experimental Therapeutics


A Phase I Dose Escalation Study of Biweekly Gemcitabine and Carboplatin in Completely Resected Stage IB-IIIA Nonsmall Cell Lung Cancer

Tomizawa, Yoshio; Ishihara, Shin-ichi; Iijima, Hironobu; More

American Journal of Clinical Oncology. 30(5):498-502, October 2007.

Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation for Locally Advanced Esophageal Cancer: Phase II Results of Preliminary Pharmacologic and Molecular Efforts to Mitigate Toxicity and Predict Outcomes: North Central Cancer Treatment Group (N0044)

Jatoi, Aminah; Martenson, James A.; Foster, Nathan R.; More

American Journal of Clinical Oncology. 30(5):507-513, October 2007.



COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin

Cascinu, Stefano; Scartozzi, Mario; Carbonari, Giovanna; More

American Journal of Clinical Oncology. 30(5):526-530, October 2007.

Head and Neck


Oncology Education